How can I protect my bones, muscles and heart after menopause?

Oestrogen decline around menopause contributes to faster bone loss and changes in fat distribution, cholesterol and metabolism. Muscle also tends to decline with age. These changes can affect fracture, disability, diabetes and cardiovascular risk, but menopause alone does not predict what will happen to an individual.

Risk is shaped by age, family and medical history, pregnancy history, smoking, activity, nutrition, medicines and conditions such as diabetes, kidney disease or rheumatoid arthritis. Early menopause and premature ovarian insufficiency need particular attention because lower hormone exposure begins sooner.

Bones respond to loading and muscles respond to progressive resistance. A useful programme combines weight-bearing activity, such as brisk walking, stair climbing or suitable impact exercise, with strength work and balance practice. The right starting point depends on current strength, falls risk, pain, previous fracture and other health conditions.

Increase activity gradually. Seek tailored advice before higher-impact or loaded exercise if you have osteoporosis, a previous low-trauma fracture, significant pain, poor balance, pelvic-floor symptoms, a heart or lung condition or a long break from activity. The aim is safe progression and function, not pushing through warning symptoms.

No. A dual-energy X-ray absorptiometry scan, usually called DXA or a bone-density scan, is most useful when age or risk factors make the result likely to change care. Reasons to discuss it include POI or early menopause, a low-trauma fracture, long-term use of medicines that weaken bone, low body weight, falls, a strong family history or a condition associated with bone loss.

A confirmed POI diagnosis is a specific exception: the international POI guideline recommends a bone-density scan at diagnosis, with repeat timing based on the result and risk. For other people, a normal result does not remove every future risk, and repeat timing depends on the first result and whether the risk profile changes. A low result may lead to assessment for contributing causes and a plan that can include activity, nutrition, falls prevention and, for some people, medicine. Ask what decision the scan will inform rather than requesting it as a universal menopause test.

Calcium, vitamin D, protein and enough overall nutrition support bone and muscle. Food sources of calcium include dairy foods or calcium-fortified alternatives, some fish eaten with bones, tofu set with calcium, and selected nuts, seeds and leafy vegetables. Needs vary with age, food pattern and health conditions.

Food is usually the first way to meet calcium needs. A GP or dietitian can help estimate intake and decide whether a supplement would fill a genuine gap. Vitamin D advice should account for deficiency risk, skin type, season, location, sun protection and skin-cancer risk; testing or a supplement is useful in some circumstances rather than automatically for everyone.

Blood pressure, cholesterol, diabetes, smoking, kidney health, family history and pregnancy complications can all affect cardiovascular risk. Many cause no symptoms. A cardiovascular risk assessment brings the factors together rather than treating menopause as a diagnosis of heart disease.

Australian Heart Health Check guidance uses age and clinical risk: a comprehensive assessment is generally relevant from 45 to 79, from 35 to 79 for people with diabetes, and from 30 to 79 for First Nations people without known cardiovascular disease. Individual risk-factor checks may begin earlier, especially with POI, early menopause, pregnancy complications or a strong family history. Ask which assessment applies rather than assuming everyone needs the same annual blood tests.

Menopausal hormone therapy (MHT, also called HRT) should not be started solely to prevent heart disease. Its main role at the usual menopause age is treatment of appropriate menopause symptoms, with an individual discussion of benefits and risks. Bone effects may form part of that discussion, but MHT is not a substitute for cardiovascular risk assessment.

POI and early menopause are a different hormone-replacement context. Hormone treatment is usually recommended for POI until around the usual menopause age unless it is unsuitable, with benefits that include bone and broader health support.

Menopause does not replace ordinary preventive care. Depending on age and eligibility, this may include cervical, breast, bowel and lung screening, immunisation, dental and eye care, and checks for blood pressure, cholesterol and diabetes. Screening outside standard age ranges may be appropriate because of family history or another risk factor. New symptoms need diagnostic assessment rather than waiting for routine screening.

Bleeding after menopause, a new breast change or another persistent symptom needs assessment even if routine screening is up to date. Screening is designed for people without symptoms; it does not rule out a problem that develops between checks.

Choose the items relevant to you and bring them to a GP review:

The goal is a prioritised plan with review points, not a long list of tests completed all at once.

Sources supporting this guide. Source organisations have not reviewed or endorsed HerDoc.